apatinib
Apatinib is a novel, small molecule, selective vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and is the second anti-angiogenic drug to be approved in China for the treatment of advanced or metastatic gastric cancer.Reference standards of Apatinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => rac cis-3-Hydroxy Apatinib-d4 3-O-β-D-Glucuronide
[catalogue_number] => PA STI 047310
[category_ids] => ,80,95,71,98,76,75,78,70,82,117,
[chemical_name] =>
[weight] => 593.62
[form] => C30H27D4N5O8
[cas] => NA
[pslug] => rac-cis-3-hydroxy-apatinib-d4-3-o-beta-d-glucuronide-pasti047310
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
rac cis-3-Hydroxy Apatinib-d4 3-O-β-D-Glucuronide
Catalogue No.:PA STI 047310
Molecular Formula : C30H27D4N5O8
Molecular Weight : 593.62